- Home
- TOVX vs ADIL Comparison
TOVX vs ADIL Comparison
Compare TOVX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- ADIL
- Stock Information
- Founded
- TOVX 2001
- ADIL 2010
- Country
- TOVX United States
- ADIL United States
- Employees
- TOVX N/A
- ADIL N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- TOVX Health Care
- ADIL Health Care
- Exchange
- TOVX Nasdaq
- ADIL Nasdaq
- Market Cap
- TOVX 4.7M
- ADIL 4.3M
- IPO Year
- TOVX 2006
- ADIL 2018
- Fundamental
- Price
- TOVX $1.18
- ADIL $0.67
- Analyst Decision
- TOVX Strong Buy
- ADIL Strong Buy
- Analyst Count
- TOVX 1
- ADIL 1
- Target Price
- TOVX $6.00
- ADIL $8.00
- AVG Volume (30 Days)
- TOVX 23.5K
- ADIL 72.4K
- Earning Date
- TOVX 05-06-2025
- ADIL 05-13-2025
- Dividend Yield
- TOVX N/A
- ADIL N/A
- EPS Growth
- TOVX N/A
- ADIL N/A
- EPS
- TOVX N/A
- ADIL N/A
- Revenue
- TOVX N/A
- ADIL N/A
- Revenue This Year
- TOVX N/A
- ADIL N/A
- Revenue Next Year
- TOVX N/A
- ADIL N/A
- P/E Ratio
- TOVX N/A
- ADIL N/A
- Revenue Growth
- TOVX N/A
- ADIL N/A
- 52 Week Low
- TOVX $1.03
- ADIL $0.61
- 52 Week High
- TOVX $12.25
- ADIL $3.10
- Technical
- Relative Strength Index (RSI)
- TOVX 44.04
- ADIL 44.10
- Support Level
- TOVX $1.08
- ADIL $0.67
- Resistance Level
- TOVX $1.21
- ADIL $0.72
- Average True Range (ATR)
- TOVX 0.07
- ADIL 0.05
- MACD
- TOVX 0.00
- ADIL 0.00
- Stochastic Oscillator
- TOVX 57.89
- ADIL 45.67
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.